Skip to Content

Newsroom

Back

SOLTI at ASCO Annual Meeting 2018

SOLTI at ASCO Annual Meeting 2018

01 Jun 2018

  2018 ASCO ANNUAL MEETING  

During the American Society of Clinical Oncology Annual Meeting 2018, several studies led or with the participation of SOLTI will be presented.

Below you will find more information:

 
   

SOLTI-1303 PATRICIA: A phase II study of palbociclib and trastuzumab ﴾HR+ with or without letrozole﴿ in trastuzumab‐pretreated, postmenopausal patients with HER2‐positive metastatic breast cancer.

 
 


Authors: Patricia Villagrasa, Aleix Prat, Mafalda Oliveira, Lorena De La Peña, Xavier Gonzalez, Javier Cortes, Sonia Pernas Simon, Jose Rios, Jordi Canes, Eva Ciruelos

 
 

2/6/2018, 8:00 AM-11:30 AM

Hall A

Poster Session: Breast Cancer—Metastatic

Abstract TPS1101

 
 
 

Patient (pt)-reported function and symptoms in APHINITY: A randomized comparison of chemotherapy (C) + trastuzumab (H) + placebo (Pla) versus C + H + pertuzumab (P) as adjuvant therapy in pts with HER2-positive early breast cancer (EBC).

 
 


Authors: Jose Baselga, Jennifer A. Petersen, Emma Clark, Claire Barton, Eleonora Restuccia, Marion Jennifer Procter, Amir Sonnenblick, Debora Fumagalli, Damian Parlier, Amal Arahmani, Giuseppe Viale, Linda L. Reaby, Elizabeth Frank, Richard D. Gelber, Martine J. Piccart-Gebhart, Jose Bines, Gunter von Minckwitz, Sabina McGarrahan Gasper

 
 

2/6/2018, 8:00 AM-11:30 AM

Hall A

Poster Session: Breast Cancer— Local/Regional/Adjuvant

Abstract 521

 
 
 

HER2-enriched subtype and ERBB2 mRNA as predictors of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer: A combined analysis of TBCRC006/023 and PAMELA trials.

 
 


Authors: Aleix Prat, Carmine De Angelis, Tomás Pascual, Carolina Gutierrez, Antonio Llombart-Cussac, Tao Wang, Javier Cortes, Brent Neil Rexer, Jamunarani Veeraraghavan, Andres Forero-Torres, Antonio C. Wolff, Serafin Morales, Ian E. Krop, Anne Clarisse Pavlick, Begona Bermejo, Susan G. Hilsenbeck, Mafalda Oliveira, Rachel Schiff, C. Kent Osborne, Mothaffar F. Rimawi

 
 

2/6/2018, 8:00 AM-11:30 AM

Hall A

Poster Session: Breast Cancer—Local/Regional/Adjuvant

Abstract 509

Discussed at the Poster Discussion Session on Saturday, June 2, 2018, 3:00 PM - 4:15 PM, in Hall D1

 
 
 

A RB-1 loss of function gene-signature (RBsig) as a tool to predict response to neoadjuvant chemotherapy (CT) plus anti-HER2 agents (H): A substudy of the NeoALTTO trial (BIG 1-06).

 
 


Authors: Emanuela Risi, Chiara Biagioni, Matteo Benelli, Ilenia Migliaccio, Amelia McCartney, Martina Bonechi, Cristina Guarducci, Florentine Hilbers, Serena Di Cosimo, Jose Baselga, Dario Romagnoli, Giulia Boccalini, Stefania Vitale, Andrea Grilli, Silvio Bicciato, Christos Sotiriou, Laura Biganzoli, Angelo Di Leo, Luca Malorni

 
 

2/6/2018, 8:00 AM-11:30 AM

Hall A

Poster Session: Breast Cancer—Local/Regional/Adjuvant

Abstract 570

 
 
 

Association between adaptive immune signature and outcome in HER2-positive breast cancer treated with trastuzumab and lapatinib in the NCCTG-N9831 (Alliance) and NeoALTTO trials.

 
 


Authors: Saranya Chumsri, Daniel Serie, Afshin Mashadi-Hossein, Jennifer M. Kachergus, Sarah Warren, Gerardo Colon-Otero, Ann H. Partridge, Lisa A. Carey, Florentine Hilbers, Veerle Van Dooren, Eileen Holmes, Serena Di Cosimo, Olena Werner, Jens Bodo Huober, Jose Baselga, Christos Sotiriou, Edith A. Perez, Amylou C. Dueck, Alvaro Moreno-Aspitia, E Aubrey Thompson

 
 

2/6/2018, 8:00 AM-11:30 AM

Hall A

Poster Session: Breast Cancer—Local/Regional/Adjuvant

Abstract 577

 
 
 

Pregnancies during and following trastuzumab (T) and/or lapatinib (L) in patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.

 
 


Authors: Matteo Lambertini, Samuel Martel, Christine Campbell, Sebastien Guillaume, Florentine Hilbers, Uwe Schuehly, Larissa Korde, Hatem A Azim, Serena Di Cosimo, Richard Charles Tenglin, Jens Bodo Huober, Jose Baselga, Alvaro Moreno-Aspitia, Martine J. Piccart-Gebhart, Richard D. Gelber, Evandro De Azambuja, Michail Ignatiadis

 
 

4/6/2018, 1:15 PM-4:45 PM

Hall A

Poster Session: Patient and Survivor Care

Abstract 10065

 

Contacts

SOLTI Communication Area
X

En Grupo Solti utilizamos cookies, propias y de terceros, analíticas, publicitarias y de elaboración de perfiles, basadas en hábitos de navegación del usuario, para mejorar la calidad del servicio, medir la audiencia y ofrecerle publicidad que pueda ser de su interés. Puede obtener más información en nuestra Política de Cookies.

Entendemos que acepta el uso de cookies en caso de que siga navegando.

Puede gestionar las cookies y aceptarlas o rechazarlas en el Panel de Configuración.